February 26, 2026 · Form 4 insider transaction
DUNCAN BARBARA GAYLE bought 65,000 shares of OVID THERAPEUTICS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The option will vest in full on February 26, 2027, subject to the Reporting Person's continuous service through such vesting date.